Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
12/2010
12/29/2010CN101926991A Classical swine fever virus vaccine and production method thereof
12/29/2010CN101926990A Swelling cell virus vsocs gene-deleted attenuated live vaccine and preparation method and application thereof
12/29/2010CN101508978B Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof
12/29/2010CN101020053B Preparation process of inactivated rotavirus vaccine
12/29/2010CA2766377A1 Swine influenza hemagglutinin variants
12/28/2010US7858766 Nucleotide sequences coding HEV (hemorrhagic enteritis virus) or EDS (egg drop syndrome virus) capsid proteins for use in vaccinating domestic birds against pathogenic adenoviral infection
12/28/2010US7858367 includes a deleted adenovirus vector genome having the adenovirus 5' and 3' cis-elements for viral replication and encapsidation and a recombinant adeno-associated virus (AAV) vector genome flanked by the adenovirus vector genome sequences; for gene therapy
12/28/2010US7858356 Mutant paramyxovirus and method for production thereof
12/28/2010US7858099 Method for inducing an immunological response in an animal
12/28/2010US7858083 Recombinant viral vector comprising antitumor agents for use in targeted tissue therapy; gene therapy; Replication-competent adenoviral vectors which selectively replicate in cancer cells
12/23/2010WO2010148386A1 Swine-origin influenza a (h1n1) virus-like particles and methods of use thereof
12/23/2010WO2010148143A1 Improved methods for purification of recombinant aav vectors
12/23/2010WO2010146359A1 Production of viral capsids
12/23/2010WO2010146043A2 System for the heterologous expression of a viral protein in a ciliate host cell
12/23/2010US20100325760 Fagopyritol synthase genes and uses thereof
12/23/2010US20100323430 Media For Membrane Ion Exchange Chromatography
12/23/2010US20100323429 Methods for purifying baculovirus
12/23/2010US20100323428 Attenuated minus-stranded rna virus
12/23/2010US20100323403 Polypurine tract modified retroviral vectors
12/23/2010US20100323398 Baculoviruses With Enhanced Virion Production and a Method for the Production of Baculoviruses
12/23/2010US20100323342 Micro-device and method for selective and non-invasive separation and extraction of particles in polydispersed suspensions, manufacturing process and applications thereof
12/23/2010US20100323003 Flaviviridae Mutants Comprising a Deletion in the Capsid Protein for Use as Vaccines
12/23/2010US20100322971 Method for producing vaccinal viral strain of a virus of the reoviridae family
12/23/2010US20100322970 Modified influenza virus
12/23/2010US20100322969 Influenza b viruses having alterations in the hemaglutinin polypeptide
12/23/2010US20100322957 Secretion-related bacterial proteins for nlrc4 stimulation
12/23/2010US20100322903 Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof
12/23/2010CA2765799A1 System for the heterologous expression of a viral protein in a ciliate host cell
12/23/2010CA2765357A1 Production of viral capsids
12/23/2010CA2764176A1 Improved methods for purification of recombinant aav vectors
12/22/2010EP2264178A1 Vaccinia virus host range genes to increase the titer of Avipoxviruses
12/22/2010EP2264050A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof
12/22/2010EP2263686A1 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments
12/22/2010CN101921769A Recombinant adenovirus, preparation method and application thereof
12/22/2010CN101921734A Method for purifying phage through chromatography
12/22/2010CN101921733A Preparation method and application of Qbeta-2aa phage virus-like particle protein
12/22/2010CN101921732A A virus causing respiratory tract illness in susceptible mammals
12/22/2010CN101920020A New application of human MED19 genes in tumor therapy
12/22/2010CN101920012A Method for producing porcine circovirus type II recombinant capsid protein subunit vaccine by utilizing silkworm bioreactor and products thereof
12/22/2010CN101402944B EV-71 virus seed, inactivated vaccine for human and method of producing the same
12/22/2010CN101260411B Recombination bacillary viral vector skeleton plasmid and application thereof
12/21/2010US7855277 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis
12/21/2010US7854928 Injecting directly into a tumor; cancer vaccine
12/21/2010CA2387182C Lentiviral vectors for the preparation of immunotherapeutical compositions
12/16/2010WO2010142532A1 Modified bacteriophage, biosensor containing same, and method of use
12/16/2010US20100317547 Methods and compositions
12/16/2010US20100317540 Methods for producing members of specific binding pairs
12/16/2010US20100317054 PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
12/16/2010US20100317014 Compositions and methods for the isolation of nucleic acid
12/16/2010US20100316991 Human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays
12/16/2010US20100316699 Compositions and Methods for Inhibiting Viral Replication
12/16/2010US20100316670 Chimeric sle/dengue type 4 antigenic viruses
12/16/2010US20100316667 Genetically stable recombinant modified vaccinia ankara (rmva) vaccines and methods of preparation thereof
12/16/2010US20100316610 Mutant having uracil phosphoribosyl transferase activity
12/16/2010US20100316603 Combination Immunogene Therapy
12/16/2010US20100316570 Protection of Virus from Immune Cell Uptake
12/16/2010DE102010013834A1 Agent for blocking the growth or killing of bacteria, comprises phages, which contain a foreign gene for killing of the bacteria and/or a genetic modification for broadening of the host range and are Pf1 and/Pf3 phages
12/15/2010EP2261246A2 Binding polypeptides for B-lymphocyte stimulator protein (BLyS)
12/15/2010EP1933866B1 Canine influenza virus and related compositions and methods of use
12/15/2010EP1841878B1 Method for the generation of virus producing cell lines and cell lines
12/15/2010EP1749098B1 Chimeric adenoviruses for use in cancer treatment
12/15/2010EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
12/15/2010CN101918565A Replication-defective arenavirus vectors
12/15/2010CN101918561A Chimeric construct of mungbean yellow mosaic india virus (MYMIV) and its uses thereof
12/15/2010CN101918434A Functional assay to investigate unclassified sequence variants of mismatch repair genes
12/15/2010CN101914570A Method for expressing porcine reproductive and respiratory syndrome vaccine protein GP5 in bombyx mori
12/15/2010CN101914503A Canine distemper attenuated vaccine strain and application thereof
12/15/2010CN101914502A I-type canine adenovirus attenuated vaccine strain and application thereof
12/15/2010CN101914501A Foot and mouth disease virus-like particle, preparation method and application thereof
12/15/2010CN101914500A Gene-recombined H9N1 subtype avian influenza virus and application thereof
12/15/2010CN101914498A MDCK (Madin-Darby Canine Kidney) cell line for stably expressing highly pathogenic avian influenza virus (HPAIV) HA (Hemagglutinin) protein and application thereof
12/15/2010CN101914139A Human papilloma virus (HPV) capsid protein L1 polypeptide and preparation and application thereof
12/15/2010CN101912421A Methods and compositions concerning poxviruses and cancer
12/14/2010US7851607 Expression vector comprising nucleotide sequences coding porcine reproductive and respiratory syndrome polypeptide for use in generating vaccine to prevent viral infection; immunotherapy
12/14/2010US7851214 Myxoviral vector as somatic gene therapeutic tool; genetic vaccines; tissue targeted therapy; antitumor agents
12/14/2010US7851196 purifying encapsidated virus; involve subjecting the composition to hydrostatic pressure such that the viral particles lacking viral nucleic acid are selectively inactivated
12/14/2010US7851195 producing high titer, wild-type-free preparations of recombinant AAV (adeno-associated virus) virions; for use as tools in genetic engineering and gene therapy
12/14/2010US7851194 used to decrease neurovirulence; producing a WN virus immunogenic composition comprising introducing a mutation into the 3'SL of WN virus; drug screening
12/14/2010US7851142 improves/extends period of viability of packed red blood cells and platelet concentrations; improves circulation half life upon transfusion
12/14/2010US7850977 contain alphavirus 5' and alphavirus 3' replication recognition sequences and a nucleotide sequence encoding an alphavirus structural protein; alphavirus replicon particles useful as immunostimulants
12/14/2010US7850958 Recombinant double stranded RNA nucleocapsid and use of the same
12/14/2010CA2394946C Method of inactivating microorganisms
12/14/2010CA2390914C A method for expressing a functional membrane-bound receptor protein using budded baculovirus
12/14/2010CA2351010C A broad spectrum infectious bursal disease virus vaccine
12/14/2010CA2285937C Modified proteins which bind extracellular matrix components
12/14/2010CA2285666C Vectors and viral vectors, and packaging cell lines for propagating same
12/14/2010CA2238659C Recombinant birnavirus vaccine
12/09/2010WO2010141706A1 Effective vector platform for gene transfer and gene therapy
12/09/2010WO2010139193A1 Hand-foot-mouth disease vaccine, preparation method and uses thereof
12/09/2010WO2010085358A3 Flaviviruses expressing the prm, e, and ns1 proteins of other flaviviruses and uses thereof
12/09/2010US20100311171 Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
12/09/2010US20100311145 Novel use of adenoviruses and nucleic acids that code for said viruses
12/09/2010US20100311144 Mutant dna polymerases
12/09/2010US20100311123 Vector for expressing antibody fragments and a method for producing recombinant phage that displays antibody fragments by using the vector
12/09/2010US20100310601 Adeno-Associated Virus Materials and Methods
12/09/2010US20100310522 Novel Polypeptides Having Endolysin Activity and Uses Thereof
12/09/2010US20100310521 Polynucleotide sequence for the inhibition of phospholamban synthesis
12/09/2010US20100310516 Duplexed Parvovirus Vectors
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 267